missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Applied Biosystems™ TaqMan™ Array Human GPCR Panel
TaqMan™ Array Human GPCR Panel
Brand: Applied Biosystems™ 4367785
This item is not returnable.
View return policy
Description
The Applied Biosystems™ TaqMan™ Human GPCR Array is an efficient, easy-to-use micro fluidic card for quantitative gene expression analysis of human GPCR genes important in drug discovery. This product is designed with 380 TaqMan™ Gene Expression Assays arrayed in singletons in 384 wells (plus 1 control arrayed in quadruplicate) and is compatible with an upgraded Applied Biosystems 7900HT Fast Real-Time PCR System. The targets include olfactory receptors, retinal receptors, small molecule receptors, chemokine receptors and others including classic endogenous markers. This product is sold in packages of 4 cards.The array is pre-formatted and inventoried, cost-effective, convenient and easy to use without needing expensive robotics. Results are reproducible and consistent across samples, studies, and labs —the same data quality from card-to-card and lot-to-lot — even with different operators.
Specifications
Array Human GPCR Panel | |
Human | |
Dried Down | |
MGB (Minor Groove Binder) (3'), Non-Fluorescent Quencher (3'), FAM (5') | |
TaqMan™ | |
Standard | |
50 GPCR subfamilies (excludes odorant, olfactory, gustatory and pheromone receptors) |
384-well Microfluidic Card | |
Each TaqMan™ Array well contains a single TaqMan™ Assay for one 2 μL reaction. The cards should be stored at 4°C. | |
TaqMan Assay for One 2 uL Reaction | |
FAM | |
4 cards | |
Cell Cycle & Proliferation, Apoptosis, Neurobiology, Signal Transduction, Oncology, Biomarker-Related Pathway(s), Extracellular Matrix & Cell Adhesion, Reproduction, Toxicology & Drug Metabolism, Immunology, Development |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only. Not for use in diagnostic procedures.
Spot an opportunity for improvement?Share a Content Correction